Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Johnson & Johnson

NYSE: JNJHealthcare / Drug Manufacturers - Major / USA
136.38+2.07+1.54%Vol 6 089 6751Y Perf 3.60%
Feb 15th, 2019 16:00
BID136.38 ASK136.39
Open135.19 Previous Close134.31
Pre-Market134.95 After-Trading136.50
 0.64 0.48%  0.12 0.09%
Target Price
145.00 
Analyst Rating
Moderate Buy 2.33
Potencial %
6.32 
Finscreener Ranking
★+     44.98
Insiders Trans % 3/6/12M
-33/-57/-63 
Value Ranking
★★+     49.34
Insiders Value % 3/6/12M
-99/-99/-99 
Growth Ranking
★★★★+     60.93
Insiders Shares Cnt. % 3/6/12M
-99/-99/-99 
Income Ranking
★★★ —    -
Market Cap (mil)365 894 
Earnings Rating
Sell
Price Range Ratio 52wk %
58.48 
Earnings Date
22nd Jan 2019

Today's Price Range

135.01136.41

52wk Range

118.62148.99

5 Year PE Ratio Range

14.30310.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
6.51%
3 Months
-6.58%
6 Months
2.94%
1 Year
3.60%
3 Years
34.25%
5 Years
55.58%

Quotes

Name / TickerPriceChg.Chg.%
JNJ136.382.07001.54
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
 
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
-
Current Ratio
1.70
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
24.80
Leverage Ratio 2.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
66.40
EBIT Margin
22.70
EBITDA Margin
31.40
Pre-tax Profit Margin
25.60
Profit Margin
18.75
ValuationValueIndustryS&P 500US Markets
PE Ratio
23.60
PB Ratio
5.49
PS Ratios
4.34
Price to Cash Flow
16.40
Price to Free Cash Flow
54.50
Cash Flow Per Share
8.09
Price to Tangible Book
-
Book Value per Share
24.10
Enterprise Value (in ths.)
366 983 000
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
19.16
ROE last 12 Months
25.43
Return on Assets (5Y Avg)
8.25
ROA last 12 Months
9.72
Return on Capital (5Y Avg)
-
ROC last 12 Months
1.88
Return on invested Capital Q
-
Return on invested Capital Y
-
Assets Turnover
0.30
Receivables Turnover
3.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
81 581 000
Revenue per Share
30.42
Revenue Growth 3 Years
5.31
Revenue Growth 5 Years
2.26
DividendsValueIndustryS&P 500US Markets
Dividend Yield
2.73
Dividend Rate
3.60
Dividend Growth 3 Years
6.18
Dividend Growth 5 Years
6.43

Earnings HistoryEstimateReportedSurprise %
Q04 20181.951.971.03
Q03 20182.032.050.99
Q02 20182.062.101.94
Q01 20182.012.062.49
Q04 20171.721.741.16
Q03 20171.801.905.56
Q02 20171.791.832.23
Q01 20171.771.833.39
Earnings Per EndEstimateRevision %Trend
3/2019 QR2.09-3.69Negative
6/2019 QR2.331.30Positive
12/2019 FY8.57-1.04Negative
12/2020 FY9.20-0.86Negative
Next Report Date-
Estimated EPS Next Report1.95
Estimates Count7
EPS Growth Next 5 Years %7.30
Volume Overview
Volume6 089 675
Shares Outstanding (in ths.)2 682 902
Trades Count21 526
Dollar Volume594 472 407
Avg. Volume7 553 198
Avg. Weekly Volume5 587 326
Avg. Monthly Volume7 671 742
Avg. Quarterly Volume10 034 093

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

25%75%

Bearish Bullish

53%47%

Bearish Bullish

50%50%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (25.00 %)
4 (33.33 %)
4 (33.33 %)
Moderate Buy
2 (16.67 %)
2 (16.67 %)
2 (16.67 %)
Hold
7 (58.33 %)
6 (50.00 %)
6 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.33
Moderate Buy
2.17
Moderate Buy
2.17

There are no comments yet.

News